Literature DB >> 27511624

Ribonucleotides and Transcription-Associated Mutagenesis in Yeast.

Jang-Eun Cho1, Sue Jinks-Robertson2.   

Abstract

High levels of transcription stimulate mutation rates in microorganisms, and this occurs primarily through an enhanced accumulation of DNA damage. The major source of transcription-associated damage in yeast is Topoisomerase I (Top1), an enzyme that removes torsional stress that accumulates when DNA strands are separated. Top1 relieves torsional stress by nicking and resealing one DNA strand, and some Top1-dependent mutations are due to trapping and processing of the covalent cleavage intermediate. Most, however, reflect enzyme incision at ribonucleotides, which are the most abundant noncanonical component of DNA. In either case, Top1 generates a distinctive mutation signature composed of short deletions in tandem repeats; in the specific case of ribonucleotide-initiated events, mutations reflect sequential cleavage by the enzyme. Top1-dependent mutations do not require highly activated transcription, but their levels are greatly increased by transcription, which partially reflects an interaction of Top1 with RNA polymerase. Recent studies have demonstrated that Top1-dependent mutations exhibit a strand bias, with the nature of the bias differing depending on the transcriptional status of the underlying DNA. Under low-transcription conditions, most Top1-dependent mutations arise in the context of replication and reflect incision at ribonucleotides incorporated during leading-strand synthesis. Under high-transcription conditions, most Top1-dependent events arise when the enzyme cleaves the non-transcribed strand of DNA. In addition to increasing genetic instability in growing cells, Top1 activity in transcriptionally active regions may be a source of mutations in quiescent cells.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Topoisomerase 1; mutagenesis; ribonucleotides; transcription

Mesh:

Substances:

Year:  2016        PMID: 27511624      PMCID: PMC5296399          DOI: 10.1016/j.jmb.2016.08.005

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  81 in total

1.  Mutational spectrum analysis of RNase H(35) deficient Saccharomyces cerevisiae using fluorescence-based directed termination PCR.

Authors:  J Z Chen; J Qiu; B Shen; G P Holmquist
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

Review 2.  Growth inhibition mediated by excess negative supercoiling: the interplay between transcription elongation, R-loop formation and DNA topology.

Authors:  Marc Drolet
Journal:  Mol Microbiol       Date:  2006-02       Impact factor: 3.501

3.  GINS maintains association of Cdc45 with MCM in replisome progression complexes at eukaryotic DNA replication forks.

Authors:  Agnieszka Gambus; Richard C Jones; Alberto Sanchez-Diaz; Masato Kanemaki; Frederick van Deursen; Ricky D Edmondson; Karim Labib
Journal:  Nat Cell Biol       Date:  2006-03-12       Impact factor: 28.824

4.  Activation-induced cytidine deaminase action is strongly stimulated by mutations of the THO complex.

Authors:  Belén Gómez-González; Andrés Aguilera
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-08       Impact factor: 11.205

5.  RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription.

Authors:  Laura Baranello; Damian Wojtowicz; Kairong Cui; Ballachanda N Devaiah; Hye-Jung Chung; Ka Yim Chan-Salis; Rajarshi Guha; Kelli Wilson; Xiaohu Zhang; Hongliang Zhang; Jason Piotrowski; Craig J Thomas; Dinah S Singer; B Franklin Pugh; Yves Pommier; Teresa M Przytycka; Fedor Kouzine; Brian A Lewis; Keji Zhao; David Levens
Journal:  Cell       Date:  2016-04-07       Impact factor: 41.582

6.  A sensitive genetic assay for the detection of cytosine deamination: determination of rate constants and the activation energy.

Authors:  L A Frederico; T A Kunkel; B R Shaw
Journal:  Biochemistry       Date:  1990-03-13       Impact factor: 3.162

7.  Somatic hypermutation of immunoglobulin genes is linked to transcription initiation.

Authors:  A Peters; U Storb
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

8.  RNase H2-initiated ribonucleotide excision repair.

Authors:  Justin L Sparks; Hyongi Chon; Susana M Cerritelli; Thomas A Kunkel; Erik Johansson; Robert J Crouch; Peter M Burgers
Journal:  Mol Cell       Date:  2012-08-02       Impact factor: 17.970

9.  Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity.

Authors:  Bjoern Hiller; Martin Achleitner; Silke Glage; Ronald Naumann; Rayk Behrendt; Axel Roers
Journal:  J Exp Med       Date:  2012-07-16       Impact factor: 14.307

10.  RNA∶DNA hybrids initiate quasi-palindrome-associated mutations in highly transcribed yeast DNA.

Authors:  Nayun Kim; Jang-Eun Cho; Yue C Li; Sue Jinks-Robertson
Journal:  PLoS Genet       Date:  2013-11-07       Impact factor: 5.917

View more
  5 in total

1.  Both R-loop removal and ribonucleotide excision repair activities of RNase H2 contribute substantially to chromosome stability.

Authors:  Deborah A Cornelio; Hailey N C Sedam; Jessica A Ferrarezi; Nadia M V Sampaio; Juan Lucas Argueso
Journal:  DNA Repair (Amst)       Date:  2017-02-20

Review 2.  The Top1 paradox: Friend and foe of the eukaryotic genome.

Authors:  Nayun Kim; Sue Jinks-Robertson
Journal:  DNA Repair (Amst)       Date:  2017-06-09

Review 3.  Recent insights into the evolution of mutation rates in yeast.

Authors:  Robert H Melde; Kevin Bao; Nathaniel P Sharp
Journal:  Curr Opin Genet Dev       Date:  2022-07-11       Impact factor: 4.665

Review 4.  Ribonucleotide Incorporation by Eukaryotic B-Family Replicases and Its Implications for Genome Stability.

Authors:  Jessica S Williams; Thomas A Kunkel
Journal:  Annu Rev Biochem       Date:  2022-03-14       Impact factor: 27.258

Review 5.  Topoisomerases and cancer chemotherapy: recent advances and unanswered questions.

Authors:  Mary-Ann Bjornsti; Scott H Kaufmann
Journal:  F1000Res       Date:  2019-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.